Copanlisib Hydrochloride | Interleukin Related interleukin-related.com

Product Name :
Copanlisib Hydrochloride

Search keywords :
Copanlisib (dihydrochloride)

drugId :
null

Target Vo:
Phosphatidylinositol 3 kinase alpha

Target Vo Short Name :
PI3Kα

Moa_Name:
Phosphatidylinositol 3 kinase delta inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Bayer AG

Active Company_Name :
Bayer AG

Active Indication_Name:
Lymphoma, Follicular

In Active Indication_Name:
Osteosarcoma

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ctip2 Antibody
PD-L1 Antibody
p38 Antibody: p38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to p38. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts